Bobby Jenks, the celebrated former White Sox closer, passed away at 44 after battling stage 4 gastric adenocarcinoma. The two ...

The FDA approved Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma, according to a press ...

Doctors are observing a concerning rise in colon cancer among individuals under 50, potentially linked to ultra-processed ...

Sirtex Medical ("Sirtex"), a leading manufacturer of interventional oncology solutions, today announced that the U.S. Food ...

BioAtla has presented first-in-human Phase I study data of its anti-cancer therapy, BA3182, targeting those with ...

Obesity-related cancer deaths increased more than threefold between 1999 and 2020, according to an analysis of the CDC WONDER ...

("LIXTE” or the "Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that the ...

Approval was based on results from the DOORwaY90 trial, which demonstrated a 98.5% overall response rate and 100% local tumor control in patients treated with the SIR-Spheres Y-90 resin microspheres ...

In combination with Roche’s PD-L1 blocker Tecentriq, zanzalintinib bested Bayer’s Stivarga. Exelixis is positioning the drug candidate as a successor to cabozantinib, which is set to lose patent ...

Rising colorectal diseases in young adults are linked to diet, stress, inactivity & more. Learn key habits to avoid to ...

The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in ...